Pfizer Seeks Authorization for Second COVID-19 Booster

  • by:
  • 08/19/2022

Pfizer and BioNTech on Tuesday requested U.S. regulators to authorize a second COVID-19 booster for seniors. 

The companies said that Israeli data suggests that people over the age of 65 would benefit from a fourth dose. 

“The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths. It’s not that good against infections,” Pfizer CEO Albert Bourla told CBS on Sunday, per Fox News. “But, we are just submitting those data to the FDA and then we will see what the experts also will say outside Pfizer.” 

As of now, a fourth dose is only recommended for those with severely weakened immune systems. 

In a Tuesday press release, Pfizer also cited “emerging evidence” and data from Kaiser Permanente in southern California, which “suggests that effectiveness against both symptomatic COVID-19 and severe disease caused by omicron wanes 3 to 6 months after receipt of an initial booster dose.” 

N/A by N/A is licensed under N/A

Opinion

View All

Parents Say NYC Children Are Seeking Therapy to Cope With Crime, Vagrants

In some cases, it has gotten to the point where kids don’t want to go outside....

Obama's Secret Service Detail Parks in Handicapped Spot for Two Hours as He Dines in Fancy LA Restaurant

The large, unmarked vehicle was spotted backing into the parking space near the entrance of the trend...

WATCH: Jen Psaki Warns that Dems 'Will Lose' if Election Is Referendum on Biden

'If it is a referendum on the president, they will lose and they know that.'...

WATCH: Rand Paul tells Jack Posobiec about his call to investigate Fauci and the origins of Covid

On the origins of Covid, Paul said, "I think by the time we're done with the investigation, and by th...

© 2022 Human Events, Privacy Policy